Impact of an aggressive stenting strategy on initial and one-year follow-up costs in patients undergoing coronary angioplasty

Australian and New Zealand Journal of Medicine

Volumn 29, Issue 2, 1999, Pages 243-248

  Farshid, Ahmad ^a,c   Leong, B ^a   Pitney, M ^a   McCredie, R M ^b   Allan, R ^a  

^a PRINCE OF WALES HOSPITAL   (Australia)

^b Eastern Heart Clinic   (Australia)

^c CANBERRA HOSPITAL   (Australia)

Author keywords

Coronary angioplasty; Cost effectiveness; Stent

Indexed keywords

ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DILATATION; CORONARY STENT; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; HOSPITAL COST; HUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RESTENOSIS; REVASCULARIZATION; TREATMENT OUTCOME;

EID: 0032905670     PISSN: 00048291     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-5994.1999.tb00691.x     Document Type: Article

References (21)

1. 1. Ryan T, King SB III, Bauman WB et al. ACC/AHA guidelines for percutaneous transluminal coronary angioplasty: a report of the American College of Cardiology/American Heart Association Task Force on assessment of diagnostic and therapeutic procedures (Committee on percutaneous transluminal coronary angioplasty). J Am Coll Cardiol 1993; 22: 2033-54.
2. 2. Kinlay S. Cost-effectiveness of coronary angioplasty versus medical treatment: the impact of cost shifting. Aust NZ J Med 1996; 26: 20-6.
3. 3. Weintraub WS, Mauldin PD, Becker E, Kosinski AS, King SB III. A comparison of the costs of and quality of life after coronary angioplasty or coronary surgery for multivessel coronary artery disease. Circulation 1995; 92: 2831-40.
4. 4. Holmes DR, Schwarttz RS, Webster MWI. Coronary restenosis: what have we learned from angiography? J Am Coll Cardiol 1991; 17: 14B-22B.
5. 5. Serruys PW, De Jaegere P, Kiemeneij F et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994; 331: 489-95.
6. 6. Fischman DL, Leon MB, Baim DS et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994; 331: 496-501.
7. 7. Schömig A, Neumann F, Kastrati A et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med 1996; 334: 1084-9.
8. 8. Cohen DJ, Krumholz HM, Sukin CA et al. In-hospital and one-year economic outcomes after coronary stenting or balloon angioplasty: results from a randomized clinical trial: Stent Restenosis Study Investigators. Circulation 1995; 92: 2480-7.
9. 9. Goods M, Liu MW, Iyer SS et al. A cost analysis of coronary stenting without anticoagulation versus stenting with anticoagulation using warfarin. Am J Cardiol 1996; 78: 334-6.
10. 10. Peterson ED, Cowper PA, Zidar JP, Phillips HR, Mark DB. In-hospital costs of coronary stenting (with or without coumadin) compared with angioplasty. Circulation 1996; 94: I-325 (Abstr.).
11. 11. Sukin CA, Baim DS, Caputo RP et al. The impact of optimal stenting techniques on cardiac catheterization laboratory resource utilization and costs. Am J Cardiol 1997; 79: 275-80.
12. 12. Cowper PA, Peterson ED, Zidar JP, Delong ER, McCants CB, Mark DB. Coronary stent costs completely recouped in six months. Circulation 1997; 96: I-456 (Abstr.).
13. 13. Cohen DJ, van Hout B, Juliard JMJ et al. Economic outcomes after coronary stenting or balloon angioplasty in the BENESTENT II trial: the US perspective. Circulation 1997; 96: I-455 (Abstr.).
14. 14. Rodriguez AE, Bernardi VH, Ayala FP et al. Optimal coronary balloon angioplasty vs stent (OCBAS): angiographic long term follow-up results of a randomized trial. Circulation 1997; 96: I-593 (Abstr.).
15. 15. Serruys P, Azar A, Sigwart U et al. Long-term follow-up of 'stent-like' (<30% diameter stenosis post) angioplasty: a case for provisional stenting. J Am Coll Cardiol 1996; 27: 15A (Abstr.).
16. 16. Nairns CR, Holmes DR, Topol EJ. A call for provisional stenting: the balloon is back! Circulation 1998; 97: 1298-305.
17. 17. Farshid A, Pitney M, Allan R et al. Optimal coronary angioplasty without stents results in low incidence of target vessel revascularisation. Aust NZ J Med 1998; 28: 106 (Abstr.).
18. 18. Kuntz RE, Baim DS, Popma JJ et al. Late clinical results of the stent anticoagulation regimen study (STARS). Circulation 1997; 94: I-594 (Abstr.).
19. 19. Serruys P, Souza E, Belardi J et al. BENESTENT-II trial: subgroup analysis of patients assigned either to angiographic and clinical follow-up or clinical follow-up alone. Circulation 1997; 96: I-653-4 (Abstr.).
20. 20. Baim DS, Cutlip DE, Midei M et al. Acute 30-day and late clinical events in the randomized parallel group comparison of the ACS MULTI-LINK coronary stent system and the Palmaz-Schatz stent. Circulation 1997; 96: I-593 (Abstr.).
21. 21. Cutlip DE, Ho KKL, Kunts RE, Baim DS. Influence of routine angiographic follow-up on clinical restenosis outcome in the ASCENT trial. J Am Coll Cardiol 1998; 31: 139A (Abstr.).